➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
AstraZeneca
Express Scripts
Boehringer Ingelheim
Colorcon

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Bethanechol chloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for bethanechol chloride and what is the scope of patent protection?

Bethanechol chloride is the generic ingredient in four branded drugs marketed by Odyssey Pharms, Able, Actavis Elizabeth, Amneal Pharm, Ascot, Discovery Therap, Heritage Pharma, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lannett Co Inc, Sandoz, Sun Pharm Inds Inc, Upsher Smith Labs, Watson Labs, Wockhardt, Chartwell Rx, and Glenwood, and is included in fifty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for bethanechol chloride. Nine suppliers are listed for this compound.

Summary for bethanechol chloride
Recent Clinical Trials for bethanechol chloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rajavithi HospitalPhase 4

See all bethanechol chloride clinical trials

Pharmacology for bethanechol chloride
Medical Subject Heading (MeSH) Categories for bethanechol chloride
Anatomical Therapeutic Chemical (ATC) Classes for bethanechol chloride

US Patents and Regulatory Information for bethanechol chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 084689-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Lannett Co Inc BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 040677-003 Mar 27, 2008 AA RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Odyssey Pharms URECHOLINE bethanechol chloride TABLET;ORAL 088440-001 May 29, 1984 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Watson Labs BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 084402-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
AstraZeneca
Express Scripts
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.